Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis

Molecular Endocrinology

Volumn 17, Issue 4, 2003, Pages 677-691

  Terrillon, Sonia ^a,c   Durroux, Thierry ^a   Mouillac, Bernard ^a   Breit, Andreas ^c   Ayoub, Mohammed A ^b   Taulan, Magali ^a   Jockers, Ralf ^b   Barberis, Claude ^a   Bouvier, Michel ^c,d  

^a INSERM   (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN RECEPTOR; RECEPTOR SUBTYPE; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ARTICLE; BIOLUMINESCENCE; BIOSYNTHESIS; CELL FRACTIONATION; CONTROLLED STUDY; DIMERIZATION; EMBRYO; ENDOPLASMIC RETICULUM; ENERGY TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOPHYSICS; CELLS, CULTURED; DIMERIZATION; HUMANS; KIDNEY; LIGANDS; LUMINESCENT MEASUREMENTS; LUMINESCENT PROTEINS; MORPHOLINES; PRECIPITIN TESTS; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPIRO COMPOUNDS; SUBCELLULAR FRACTIONS;

HOMO;

EID: 0037384043     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0222     Document Type: Article

References (51)

1. Bockaert J, Pin J-P 1999 Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723-1729
2. Angers S, Salahpour A, Bouvier M 2002 Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409-435
3. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, Gerald C 1998 GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674-679
4. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH 1998 Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396:679-682
5. Kaupmann K, Malitschek B, Schuler V, Held J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B 1998 GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683-687
6. Jordan BA, Devi LA 1999 G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700
7. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF 2000 Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135
8. Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, Canela EI, Rondin S, Lew JY, Watson S, Zoli M, Agnati LF, Verniera P, Lluis C, Ferre S, Fuxe K, Franco R 2000 Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 97:8606-8611
9. Abdalla S, Lother H, Quitterer U 2000 AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407:94-98
10. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC 2000 Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 275:7862-7869
11. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC 2000 Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154-157
12. Pfeiffer M, Koch T, Schröder H, Laugsch, M, Höllt V, Schulz S 2002 Heterodimerization of somatostatin and opioid receptors cross-modulates phoshorylation, internalization and desensitization. J Biol Chem 277:19762-19772
13. Bouvier M 2001 Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2:274-286
14. George SR, O'Dowd BF, Lee SP 2002 G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 10:808-820
15. Margeta-Mitrovic M, Jan YN, Jan LY 2000 A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27:97-106
16. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, Zuker CS 2001 Mammalian sweet taste receptors. Cell 106:381-390
17. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, Ryba NJ, Zuker CS 2002 An amino-acid taste receptor. Nature 416:199-202
18. Barberis C, Mouillac B, Durroux T 1998 Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 156:223-229
19. Tence M, Guillon G, Bottari S, Jard S 1990 Labelling of vasopressin and oxytocin receptors from the human uterus. Eur J Pharmacol 191:427-436
20. Clerget MS, Elalouf JM, Germain G 1997 Quantitative reverse transcription and polymerase chain reaction analysis of oxytocin and vasopressin receptor mRNAs in the rat uterus near parturition. Mol Cell Endocrinol 136:79-89
21. Barberis C, Tribollet E 1996 Vasopressin and oxytocin receptors in the central nervous system. Crit Rev Neurobiol 10:119-154
22. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F 1993 Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 92:2339-2345
23. 2+ in rat medullary collecting tubules. Am J Physiol 265:F35-F45
24. Gonzalez CB, Figueroa CD, Reyes CE, Caorsi CE, Troncoso S, Menzel D 1997 Immunolocalization of V1 vasopressin receptors in the rat kidney using anti-receptor antibodies. Kidney Int 52:1206-1215
25. Arpin-Bott MP, Waltisperger E, Freund-Mercier MJ, Stoeckel ME 1999 Historadioautographic localization, pharmacology and ontogeny of V1a vasopressin binding sites in the rat kidney. Nephron 83:74-84
26. Schulz A, Grosse R, Schultz G, Guderman T, Schoneberg T 2000 Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors. J Biol Chem 275:2381-2389
27. Petäjä-Repo UE, Hogue M, Laperrière A, Walker P, Bouvier M 2000 Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human δ opioid receptor. J Biol Chem 275:13727-13736
28. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, Jockers R 2002 Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277:21522-21528
29. Issafras H, Angers S, Bulenger S, Blanpain, C, Parmentier M, Labbé-Jullié C, Bouvier M, Marullo S 2002 Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 277:34666-34673
30. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA 2000 Heterodimerization of μ and δ opioid receptors: a role in opiate synergy. J Neurosci 20[RC110]:1-5
31. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de Ana A, Jones DR, Toran JL, Martinez AC 2001 Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20:2497-2507
32. Havlickova M, Prezeau L, Duthey B, Bettler B, Pin JP, Blahos J 2002 The intracellular loops of the GB2 subunit are crucial for G-protein coupling of the heteromeric γ-aminobutyrate B receptor. Mol Pharmacol 62:343-350
33. Hamm HE 2001 How activated receptors couple to G proteins. Proc Natl Acad Sci USA 98:4819-4821
34. Nagaya N, Papazian DM 1997 Potassium channel α and subunits assemble in the endoplasmic reticulum. J Biol Chem 272:3022-3027
35. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like-receptor. Nature 393:333-339
36. Dwyer ND, Troemel ER, Sengupta P, Bargmann CI 1998 Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein. Cell 93:455-466
37. Hilairet S, Foord SM, Marshall FH, Bouvier M 2001 Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J Biol Chem 276:29575-29581
38. Pierce KL, Lefkowitz RJ 2001 Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci 2:727-733
39. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K 2000 Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407:971-977
40. Dann CE, Hsieh J-C, Rattner A, Sharma D, Nathans J, Leahy DJ 2001 Insights into Wnt binding and signalling from the structures of two frizzled cysteine-rich domains. Nature 412:86-90
41. Hovius R, Vallotton P, Wohland T, Vogel H 2000 Fluorescence techniques: shedding light on ligand-receptor interactions. Trends Pharmacol Sci 21:266-273
42. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M 2000 Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97:3684-3689
43. Wurch T, Matsumoto A, Pauwels PJ 2001 Agonist-independant and -dependant oligomerization of dopamine D2 receptors by fusion to fluorescent proteins. FEBS Lett 507:109-113
44. Kroeger KM, Hanyaloglu AC, Seeber RM, Miles LE, Eidne KA 2001 Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence energy transfer. J Biol Chem 276:12736-12743
45. Cheng ZJ, Miller LJ 2001 Agonist-dependent dissociation of oligomeric complexes of G-protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 276:48040-48047
46. Mc Vey M, Ramsay D, Kellet E, Rees S, Wilson S, Pope A.J. and Milligan G 2001 Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human δ-opioid receptor displays constitutive oligomerization at the cell surface which is not regulated by receptor occupancy. J Biol Chem 276:14092-14099
47. Overton MC, Blumer KJ 2000 G-protein-coupled receptors function as oligomers in vivo. Curr Biol 10:341-344
48. Mellon P, Parker V, Gluzman Y, Maniatis T 1981 Identification of DNA sequences required for transcription of the human αl-globin gene in a new SV40 host-vector system. Cell 27:279-288
49. Durroux T, Peter M, Turcatti G, Chollet A, Balestre MN, Barberis C, Seyer R 1999 Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications. J Med Chem 42:1312-1319
50. Bazin H, Préaudat M, Trinquet E, Mathis G 2001 Homogeneous time resolved fluorescence resonance energy transfer using rare earth cryptates as tool for probing molecular interactions in biology. Spectrochim Acta A Mol Biomol Spectrosc 57:2197-2211
51. Wong YH, Federman A, Pace AM, Zachary I, Evans T, Pouyssegur J, Bourne HR 1991 Mutant α subunits of Gi2 inhibit cAMP accumulation. Nature 351:63-65